Benjamin Hohl - Mar 4, 2025 Form 4 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Benjamin Hohl
Stock symbol: ELVN
Transactions as of: Mar 4, 2025
Transactions value $: $24,800
Form type: 4
Date filed: 3/6/2025, 06:02 PM
Previous filing: Mar 3, 2025
Next filing: Mar 26, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELVN	Common Stock	Options Exercise	$24.8K	+10K	+76.92%	$2.48	23K	Mar 4, 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELVN	Stock Option (right to buy)	Options Exercise	$0	-10K	-7%	$0.00	133K	Mar 4, 2025	Common Stock	10K	$2.48	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.